Aging/Drugs & interventions

a.AGINGRESEARCH IN PROGRESS

🇩🇪🇬🇧

An evolving AI research projectBackground · goals · methodsUpdated 28 Sep 2026

Drugs & interventions

Connect the literature. Challenge assumptions. Understand function.

New: a living list of human functional outcomes, preclinical candidates and hypotheses →

Experimental targets, translational barriers and safety.

This page tracks experimental intervention directions, not medicine recommendations.

• Signalling: specify location, cell type and timing of perturbation.
• Protein activity and iron handling: separate target effects from general stress reduction.
• Senescence: distinguish repair phases from chronic tissue contexts.
• Translation: require human target engagement, dose-response relationships, off-target analysis and long-term safety.

Initial status: no clinically confirmed human rejuvenation treatment established here. No finding justifies self-medication; this project supplies no doses or personal treatment plans. Trial registrations will be distinguished explicitly from trial results.

Experimental starting sources: AG-S01 · AG-S04 · AG-S08 · AG-S09

Current report with sources and evidence · Status rules

Continue exploring

Approaches to aging

Evidence and functional outcomes

→

Evidence chain

How studies generate new questions

Research colloquium

16 foundation assignments + 4 new deep dives

a.AGINGRESEARCH IN PROGRESS

Project overviewGoals & methodsEvidence chain

AI-assisted literature research and model building. No laboratory or clinical studies conducted by this project. No personal treatment plans.

Image credits · Illustrations, not project data: Axolotl — LoKiLeCh (CC BY-SA 3.0) · Neuron — explorebiology (Explore Biology) (CC BY 4.0) · DNA — Biochemlife (CC BY-SA 4.0) · Bovine endothelial cells — Erin Rod (CC BY 4.0)